Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$56.20
-2.33-3.98%
At Close: -
$56.26
0.060.11%
After Hours: 7:51 PM EDT
15 minutes delayed
Comments
Loading...
Halozyme Therapeutics (HALO) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestOverview Rating
Good
Halozyme Therapeutics (NASDAQ:HALO) Stock Quotes, Forecast and News Summary
Halozyme Therapeutics Stock (NASDAQ: HALO) stock price, news, charts, stock research, profile.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Halozyme Therapeutics (HALO) stock?
You can purchase shares of Halozyme Therapeutics (NASDAQ:HALO) through any online brokerage.
Who are Halozyme Therapeutics (HALO) competitors?
Other companies in Halozyme Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), Sarepta Therapeutics (NASDAQ:SRPT) and Exact Sciences (NASDAQ:EXAS).
What is the forecast, or price target, for Halozyme Therapeutics (HALO) stock?
Halozyme Therapeutics has a consensus price target of $56.86.
What is the current price for Halozyme Therapeutics (HALO)?
The stock price for Halozyme Therapeutics (NASDAQ: HALO) is $56.26 last updated September 24, 2024 at 7:51 PM EDT.
Does Halozyme Therapeutics (HALO) pay a dividend?
There are no upcoming dividends for Halozyme Therapeutics.
When is Halozyme Therapeutics (NASDAQ:HALO) reporting earnings?
Halozyme Therapeutics’s Q3 earnings are confirmed for Monday, November 4, 2024.
Is Halozyme Therapeutics (HALO) going to split?
There is no upcoming split for Halozyme Therapeutics.
What sector and industry does Halozyme Therapeutics (HALO) operate in?
Halozyme Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.